BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 28865422)

  • 1. Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
    Semeere A; Freeman E; Wenger M; Glidden D; Bwana M; Kanyesigye M; Asirwa FC; Rotich E; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Adebamowo C; Jaquet A; Dabis F; Phiri S; Bohlius J; Egger M; Yiannoutsos CT; Wools-Kaloustian K; Martin J
    BMC Cancer; 2017 Sep; 17(1):611. PubMed ID: 28865422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa.
    Freeman E; Semeere A; Wenger M; Bwana M; Asirwa FC; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Jaquet A; Dabis F; Yumo HA; Dusingize JC; Bangsberg D; Anastos K; Phiri S; Bohlius J; Egger M; Yiannoutsos C; Wools-Kaloustian K; Martin J
    BMC Cancer; 2016 Feb; 16():65. PubMed ID: 26852390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
    Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
    Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
    Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
    Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
    Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
    AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of HIV-positive patients lost to follow-up in African treatment programmes.
    Zürcher K; Mooser A; Anderegg N; Tymejczyk O; Couvillon MJ; Nash D; Egger M;
    Trop Med Int Health; 2017 Apr; 22(4):375-387. PubMed ID: 28102610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility of Rapid Case Ascertainment for Cancer in East Africa: An Investigation of Community-Representative Kaposi Sarcoma in the Era of Antiretroviral Therapy.
    Semeere A; Byakwaga H; Laker-Oketta M; Freeman E; Busakhala N; Wenger M; Kasozi C; Ssemakadde M; Bwana M; Kanyesigye M; Kadama-Makanga P; Rotich E; Kisuya J; Sang E; Maurer T; Wools-Kaloustian K; Kambugu A; Martin J
    Cancer Epidemiol; 2021 Oct; 74():101997. PubMed ID: 34385076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporating loss to follow-up in estimates of survival among HIV-infected individuals in sub-Saharan Africa enrolled in antiretroviral therapy programs.
    Verguet S; Lim SS; Murray CJ; Gakidou E; Salomon JA
    J Infect Dis; 2013 Jan; 207(1):72-9. PubMed ID: 23100567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
    Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
    BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-associated Kaposi sarcoma in African children.
    Feller L; Khammissa RA; Gugushe TS; Chikte UM; Wood NH; Meyerov R; Lemmer J
    SADJ; 2010 Feb; 65(1):20-2. PubMed ID: 20411798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries.
    Ballif M; Christ B; Anderegg N; Chammartin F; Muhairwe J; Jefferys L; Hector J; van Dijk J; Vinikoor MJ; van Lettow M; Chimbetete C; Phiri SJ; Onoya D; Fox MP; Egger M
    Clin Infect Dis; 2022 Jan; 74(2):171-179. PubMed ID: 33993219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation and survival of patients with AIDS-related Kaposi's sarcoma in Jos, Nigeria.
    Agaba PA; Sule HM; Ojoh RO; Hassan Z; Apena L; Mu'azu MA; Badung B; Agbaji OO; Idoko JA; Kanki P
    Int J STD AIDS; 2009 Jun; 20(6):410-3. PubMed ID: 19451327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria.
    Balogun M; Meloni ST; Igwilo UU; Roberts A; Okafor I; Sekoni A; Ogunsola F; Kanki PJ; Akanmu S
    PLoS One; 2019; 14(7):e0219903. PubMed ID: 31344057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
    Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
    Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in HIV-associated Kaposi sarcoma.
    Dalla Pria A; Pinato DJ; Bracchi M; Bower M
    F1000Res; 2019; 8():. PubMed ID: 31297181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss to follow-up among youth accessing outpatient HIV care and treatment services in Kisumu, Kenya.
    Ojwang' VO; Penner J; Blat C; Agot K; Bukusi EA; Cohen CR
    AIDS Care; 2016; 28(4):500-7. PubMed ID: 26565428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
    Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
    J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi sarcoma incidence in Mozambique: national and regional estimates.
    Meireles P; Albuquerque G; Vieira M; Foia S; Ferro J; Carrilho C; Lunet N
    Eur J Cancer Prev; 2015 Nov; 24(6):529-34. PubMed ID: 25494288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of patients lost to follow-up after antiretroviral therapy initiation in rural north-eastern South Africa.
    Ambia J; Kabudula C; Risher K; Xavier Gómez-Olivé F; Rice BD; Etoori D; Reniers G
    Trop Med Int Health; 2019 Jun; 24(6):747-756. PubMed ID: 30920699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
    ; Rohner E; Schmidlin K; Zwahlen M; Chakraborty R; Clifford G; Obel N; Grabar S; Verbon A; Noguera-Julian A; Collins IJ; Rojo P; Brockmeyer N; Campbell M; Chêne G; Prozesky H; Eley B; Stefan DC; Davidson A; Chimbetete C; Sawry S; Davies MA; Kariminia A; Vibol U; Sohn A; Egger M; Bohlius J
    Clin Infect Dis; 2016 Nov; 63(9):1245-1253. PubMed ID: 27578823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.